Explore the detailed record of transactions filed by Zalevsky Jonathan, Directeur de la Recherche et du Développement. Insider active across 2 companies, notably NEKTAR THERAPEUTICS. Aggregated, 29 disclosures have been published. Breakdown: 0 buy · 22 sells. Total volume traded: €1.4m. History available since 17 May 2021. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Zalevsky Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Zalevsky Jonathan is Director of Research and Development. He has made 28 filings in total, and across the sampled recent filings between 2021-05-19 and 2026-02-20, the activity consists of sales totaling EUR 1,373,233, with no purchases reported.